Our dermatology trial portfolio spans key areas, including:
Psoriasis and psoriatic arthritis
Atopic dermatitis and eczema
Acne and rosacea
Urticaria, vitiligo, and alopecia areata
Rare dermatologic conditions and topical drug delivery systems
We offer a full suite of services, including:
Protocol development with dermatology-specific efficacy and safety endpoints
Access to a wide investigator network and large patient populations through 100+ qualified dermatology sites
Support for imaging-based assessments and standardized scoring scales (e.g., PASI, IGA, EASI)
Regulatory strategy and NDA support, with 11 successful submissions to date
With strong collaborations with China's leading dermatology KOLs and institutions, GCP ClinPlus ensures faster recruitment, reliable data capture, and smooth regulatory navigation. Whether for biologics, small molecules, topicals, or devices, we provide tailored solutions that bring dermatologic innovations to market with confidence.